METHAZOLAMIDE

METHAZOLAMIDE was reported 345 times

METHAZOLAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEREDITARY RETINAL DYSTROPHY 1 0.1250
1 DIVERTICULITIS MECKEL'S 1 0.1000
2 NERVE DEGENERATION 13 0.0722
3 MALIGNANT GLAUCOMA 1 0.0556
4 INTRACRANIAL HAEMANGIOMA 1 0.0357
5 DIALYSIS DEVICE COMPLICATION 1 0.0286
6 DIABETIC GASTROPATHY 1 0.0250
7 PERCEPTUAL DISTURBANCE 1 0.0227
8 ATOPY 5 0.0180
9 PAGE KIDNEY 1 0.0167
10 ARCUS LIPOIDES 1 0.0159
11 VASCULAR HEADACHE 1 0.0104
12 PERIPHERAL NERVE PALSY 1 0.0088
13 CONJUNCTIVAL IRRITATION 1 0.0074
14 VISUAL PERSEVERATION 1 0.0068
15 RENAL MASS 13 0.0063
16 RENAL NEOPLASM 13 0.0061
17 SUTURE RUPTURE 4 0.0058
18 ACUTE MYOPIA 1 0.0055
19 ABDOMINAL RIGIDITY 13 0.0048
20 CHOROIDAL DETACHMENT 2 0.0036
21 POST CHOLECYSTECTOMY SYNDROME 1 0.0035
22 EPIDERMOLYSIS BULLOSA 1 0.0032
23 SMALL CELL CARCINOMA 1 0.0029
24 INTRAOCULAR PRESSURE TEST ABNORMAL 2 0.0028
25 DIABETIC GASTROPARESIS 1 0.0027
26 CORNEAL OEDEMA 6 0.0027
27 CHOROIDAL EFFUSION 2 0.0025
28 PROCEDURAL HEADACHE 1 0.0024
29 PERICARDITIS CONSTRICTIVE 1 0.0024
30 SEXUALLY TRANSMITTED DISEASE 1 0.0023
31 METASTASES TO PANCREAS 1 0.0023
32 URETHRAL DISORDER 1 0.0021
33 PERIPHERAL ARTERY STENOSIS 1 0.0021
34 IRIS ADHESIONS 1 0.0019
35 METASTASIS 13 0.0018
36 OCCIPITAL NEURALGIA 1 0.0018
37 BLOOD PRESSURE DIASTOLIC DECREASED 13 0.0018
38 THOUGHT BLOCKING 1 0.0017
39 RENAL CYST 13 0.0016
40 ELBOW OPERATION 1 0.0016
41 ARTHRITIS REACTIVE 1 0.0016
42 BACILLUS INFECTION 1 0.0016
43 SCLERAL DISCOLOURATION 1 0.0015
44 GALLBLADDER PAIN 1 0.0015
45 POSTOPERATIVE ADHESION 1 0.0015
46 ARACHNOIDITIS 1 0.0014
47 SJS-TEN OVERLAP 1 0.0014
48 MYOFASCIAL PAIN SYNDROME 1 0.0014
49 CARCINOID TUMOUR 1 0.0013
50 LARGE INTESTINAL OBSTRUCTION 3 0.0013
51 IDIOPATHIC INTRACRANIAL HYPERTENSION 3 0.0013
52 PRODUCT INEFFECTIVE 1 0.0013
53 PRODUCT DROPPER ISSUE 1 0.0013
54 RETINAL PIGMENTATION 1 0.0013
55 FEAR OF FALLING 1 0.0012
56 PANCREATITIS RELAPSING 1 0.0012
57 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
58 VACCINATION COMPLICATION 1 0.0012
59 AMAUROSIS 1 0.0012
60 ANGLE CLOSURE GLAUCOMA 3 0.0012
61 INTRAOCULAR PRESSURE INCREASED 14 0.0011
62 CONJUNCTIVAL OEDEMA 1 0.0010
63 BONE DEMINERALISATION 1 0.0009
64 PRODUCT NAME CONFUSION 1 0.0009
65 PILOERECTION 1 0.0009
66 PRODUCT SELECTION ERROR 1 0.0009
67 MACULOPATHY 3 0.0008
68 MYOPIA 2 0.0008
69 RENAL TUBULAR INJURY 1 0.0008
70 SENSORY DISTURBANCE 13 0.0008
71 MIDDLE INSOMNIA 15 0.0008
72 HYPERPARATHYROIDISM SECONDARY 2 0.0008
73 BENIGN INTRACRANIAL HYPERTENSION 1 0.0008
74 CARDIOACTIVE DRUG LEVEL INCREASED 1 0.0008
75 ANION GAP INCREASED 1 0.0007
76 RENAL ARTERY STENOSIS 1 0.0007
77 PROTHROMBIN TIME SHORTENED 1 0.0007
78 PULMONARY SEPSIS 1 0.0007
79 HERNIA 13 0.0007
80 INJECTION SITE PARAESTHESIA 1 0.0007
81 CHRONIC MYELOID LEUKAEMIA 3 0.0006
82 IRIDOCYCLITIS 2 0.0006
83 KERATOPATHY 1 0.0006
84 HEART RATE IRREGULAR 14 0.0006
85 OPTIC ATROPHY 1 0.0006
86 HEPATIC NEOPLASM 2 0.0006
87 LAZINESS 1 0.0006
88 RETINITIS 1 0.0006
89 MEDICAL DEVICE REMOVAL 1 0.0006
90 DIFFUSE ALOPECIA 1 0.0005
91 RETINOPATHY 2 0.0005
92 HYPERTENSIVE HEART DISEASE 1 0.0005
93 CLAVICLE FRACTURE 2 0.0005
94 HEPATIC MASS 1 0.0005
95 THERAPEUTIC PRODUCT INEFFECTIVE 2 0.0005
96 OCULAR HYPERTENSION 1 0.0005
97 URINE ODOUR ABNORMAL 3 0.0005
98 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
99 INTERNATIONAL NORMALISED RATIO DECREASED 2 0.0005
100 EYELID PAIN 1 0.0005
101 IMMUNE-MEDIATED HEPATITIS 1 0.0005
102 GLAUCOMA 9 0.0005
103 ANAL INCONTINENCE 4 0.0004
104 NEPHROGENIC ANAEMIA 2 0.0004
105 DISCOURAGEMENT 1 0.0004
106 HEART RATE DECREASED 15 0.0004
107 VOLVULUS 1 0.0004
108 BONE DENSITY DECREASED 13 0.0004
109 EYE OEDEMA 1 0.0004
110 DERMAL CYST 1 0.0004
111 DENTAL OPERATION 1 0.0004
112 MOVEMENT DISORDER 13 0.0004
113 DEVICE INFUSION ISSUE 1 0.0004
114 EYELID IRRITATION 1 0.0004
115 PHLEBITIS 2 0.0004
116 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
117 BLOOD POTASSIUM ABNORMAL 1 0.0004
118 HYPERLACTACIDAEMIA 1 0.0004
119 GASTROINTESTINAL INJURY 1 0.0004
120 HYDROCEPHALUS 2 0.0004
121 ULCERATIVE KERATITIS 1 0.0004
122 INTRACRANIAL PRESSURE INCREASED 2 0.0004
123 DRUG TOLERANCE DECREASED 1 0.0004
124 PANCREATIC CARCINOMA METASTATIC 1 0.0004
125 EYELID MARGIN CRUSTING 1 0.0003
126 EMERGENCY CARE 1 0.0003
127 RETINAL DETACHMENT 3 0.0003
128 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
129 FOREIGN BODY IN THROAT 1 0.0003
130 FOREIGN BODY SENSATION IN EYES 2 0.0003
131 POOR VENOUS ACCESS 3 0.0003
132 VIITH NERVE PARALYSIS 1 0.0003
133 WEIGHT FLUCTUATION 3 0.0003
134 NECK PAIN 16 0.0003
135 BRADYCARDIA 15 0.0003
136 LUNG TRANSPLANT 1 0.0003
137 CONJUNCTIVAL HYPERAEMIA 1 0.0003
138 VISUAL FIELD DEFECT 2 0.0003
139 HYPERACUSIS 1 0.0003
140 EYE PAIN 15 0.0003
141 REBOUND EFFECT 3 0.0003
142 ORAL INFECTION 1 0.0003
143 AZOTAEMIA 1 0.0003
144 RIB FRACTURE 5 0.0002
145 AORTIC VALVE INCOMPETENCE 1 0.0002
146 TENSION HEADACHE 1 0.0002
147 HORDEOLUM 1 0.0002
148 DYSPHEMIA 1 0.0002
149 ONYCHOMYCOSIS 1 0.0002
150 HAEMORRHAGIC ANAEMIA 1 0.0002
151 STEVENS-JOHNSON SYNDROME 5 0.0002
152 PAPILLOEDEMA 1 0.0002
153 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
154 RHINORRHOEA 14 0.0002
155 SYNOVIAL CYST 1 0.0002
156 INTERCEPTED MEDICATION ERROR 1 0.0002
157 RENAL FUNCTION TEST ABNORMAL 1 0.0002
158 FEELING OF DESPAIR 1 0.0002
159 BLINDNESS UNILATERAL 3 0.0002
160 EYE INFLAMMATION 2 0.0002
161 HUMERUS FRACTURE 1 0.0002
162 VITAMIN D DEFICIENCY 2 0.0002
163 KIDNEY INFECTION 4 0.0002
164 LIGAMENT SPRAIN 2 0.0002
165 ANEURYSM 1 0.0002
166 INJECTION SITE INFLAMMATION 1 0.0002
167 HYPERNATRAEMIA 1 0.0002
168 AMNESIA 13 0.0002
169 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
170 DYSLIPIDAEMIA 1 0.0002
171 PERIPHERAL VASCULAR DISORDER 1 0.0002
172 EYE DISCHARGE 2 0.0002
173 RENAL PAIN 2 0.0002
174 STRESS FRACTURE 1 0.0002
175 ERYTHEMA OF EYELID 1 0.0002
176 ASTHENOPIA 1 0.0002
177 OCULAR DISCOMFORT 2 0.0002
178 PERIORBITAL SWELLING 1 0.0002
179 CARDIAC VALVE DISEASE 1 0.0002
180 VISUAL DISTURBANCE 1 0.0002
181 SKIN ATROPHY 1 0.0002
182 BALANCE DISORDER 15 0.0002
183 PRODUCT LABEL CONFUSION 1 0.0002
184 HYPOVOLAEMIA 1 0.0002
185 PLEURISY 1 0.0002
186 CARDIAC PACEMAKER INSERTION 1 0.0002
187 MACULAR DEGENERATION 2 0.0002
188 TYPE 1 DIABETES MELLITUS 1 0.0002
189 ADRENAL INSUFFICIENCY 2 0.0002
190 PIGMENTATION DISORDER 1 0.0002
191 NASAL DRYNESS 1 0.0002
192 PHOTOPHOBIA 3 0.0002
193 CYSTITIS 5 0.0002
194 CHOKING 3 0.0002
195 ABDOMINAL DISTENSION 16 0.0002
196 POLYP 1 0.0002
197 NEPHROLITHIASIS 7 0.0002
198 WALKING AID USER 1 0.0002
199 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
200 APPETITE DISORDER 1 0.0002
201 CHOLECYSTITIS CHRONIC 1 0.0001
202 BREAST MASS 1 0.0001
203 WRONG PRODUCT ADMINISTERED 1 0.0001
204 OCULAR HYPERAEMIA 7 0.0001
205 CROHN'S DISEASE 1 0.0001
206 PULMONARY HYPERTENSION 3 0.0001
207 BLOOD PRESSURE INCREASED 22 0.0001
208 HEART RATE INCREASED 14 0.0001
209 DIVERTICULUM 1 0.0001
210 DRY EYE 7 0.0001
211 FEAR OF INJECTION 1 0.0001
212 VISUAL IMPAIRMENT 17 0.0001
213 CHILLS 16 0.0001
214 PSYCHIATRIC SYMPTOM 1 0.0001
215 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
216 THERAPY NON-RESPONDER 6 0.0001
217 PEMPHIGOID 1 0.0001
218 LACRIMATION INCREASED 4 0.0001
219 ECONOMIC PROBLEM 2 0.0001
220 OEDEMA PERIPHERAL 16 0.0001
221 ACIDOSIS 1 0.0001
222 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
223 LUNG INFECTION 2 0.0001
224 COGNITIVE DISORDER 6 0.0001
225 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
226 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
227 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
228 NASAL DISCOMFORT 1 0.0001
229 DRUG INTOLERANCE 12 0.0001
230 MYASTHENIA GRAVIS 1 0.0001
231 POST PROCEDURAL INFECTION 1 0.0001
232 POLYURIA 1 0.0001
233 IMPAIRED HEALING 4 0.0001
234 EYE DISORDER 4 0.0001
235 EYE IRRITATION 7 0.0001
236 GENERAL PHYSICAL HEALTH DETERIORATION 14 0.0001
237 PALPITATIONS 14 0.0001
238 FACIAL PARALYSIS 1 0.0001
239 METASTASES TO LIVER 2 0.0001
240 GRIP STRENGTH DECREASED 1 0.0001
241 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
242 RESPIRATORY RATE INCREASED 1 0.0001
243 GASTROINTESTINAL INFECTION 1 0.0001
244 OROPHARYNGEAL DISCOMFORT 1 0.0001
245 LIP DRY 1 0.0001
246 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
247 HYPERGLYCAEMIA 4 0.0001
248 END STAGE RENAL DISEASE 2 0.0001
249 BRAIN NEOPLASM 1 0.0001
250 DYSURIA 4 0.0001
251 OVARIAN CANCER 1 0.0001
252 RENAL DISORDER 5 0.0001
253 BLOOD SODIUM DECREASED 2 0.0001
254 MUSCULOSKELETAL DISORDER 2 0.0001
255 HYPERSOMNIA 3 0.0001
256 HYPERCHOLESTEROLAEMIA 1 0.0001
257 SINUS BRADYCARDIA 1 0.0001
258 DIZZINESS POSTURAL 1 0.0001
259 DYSTONIA 2 0.0001
260 HAEMORRHOIDS 2 0.0001
261 INFLAMMATORY BOWEL DISEASE 1 0.0001
262 RENAL TUBULAR NECROSIS 1 0.0001
263 PRESCRIBED UNDERDOSE 2 0.0001
264 BLOOD POTASSIUM DECREASED 3 0.0001
265 EMPHYSEMA 1 0.0001
266 CONFUSIONAL STATE 16 0.0001
267 DRUG LEVEL DECREASED 1 0.0001
268 BLINDNESS 4 0.0001
269 SLUGGISHNESS 1 0.0001
270 NASOPHARYNGITIS 18 0.0001
271 SINUSITIS 10 0.0001
272 VENTRICULAR EXTRASYSTOLES 1 0.0001
273 VISION BLURRED 13 0.0001
274 BREAST CANCER METASTATIC 1 0.0001
275 BIPOLAR DISORDER 1 0.0001
276 PRODUCT DISPENSING ERROR 2 0.0001
277 PULMONARY THROMBOSIS 1 0.0001
278 VISUAL ACUITY REDUCED 3 0.0001
279 HEPATOTOXICITY 2 0.0001
280 SKIN INFECTION 1 0.0001
281 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
282 EYE INFECTION 1 0.0001
283 MITRAL VALVE INCOMPETENCE 1 0.0001
284 CHOLECYSTECTOMY 1 0.0001
285 GASTRIC DISORDER 3 0.0001
286 METASTASES TO LUNG 1 0.0001
287 ELECTROLYTE IMBALANCE 1 0.0001
288 EYELID OEDEMA 1 0.0001
289 SPLENOMEGALY 1 0.0001
290 HYPERLIPIDAEMIA 1 0.0001
291 CEREBROVASCULAR ACCIDENT 14 0.0001
292 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
293 SPINAL OPERATION 1 0.0001
294 GENERALISED OEDEMA 1 0.0001
295 CYST 1 0.0001
296 CHRONIC KIDNEY DISEASE 6 0.0001
297 ROTATOR CUFF SYNDROME 1 0.0001
298 HIATUS HERNIA 1 0.0001
299 PLATELET COUNT INCREASED 1 0.0001
300 PULMONARY CONGESTION 1 0.0001
301 INFUSION RELATED REACTION 5 0.0001
302 EYE HAEMORRHAGE 1 0.0001
303 UVEITIS 1 0.0001
304 TACHYPNOEA 1 0.0001
305 AKATHISIA 1 0.0001
306 MENTAL STATUS CHANGES 2 0.0001
307 COORDINATION ABNORMAL 1 0.0001
308 PAIN IN JAW 2 0.0001
309 DIALYSIS 1 0.0001
310 ANXIETY 20 0.0001
311 ACCIDENTAL UNDERDOSE 1 0.0001
312 MYELODYSPLASTIC SYNDROME 1 0.0001
313 PAIN IN EXTREMITY 20 0.0001
314 URINARY INCONTINENCE 2 0.0001
315 RENAL INJURY 2 0.0001
316 PULMONARY MASS 1 0.0001
317 TREMOR 11 0.0001
318 OSTEOPENIA 1 0.0001
319 TINNITUS 3 0.0001
320 MUSCULOSKELETAL CHEST PAIN 1 0.0001
321 EJECTION FRACTION DECREASED 1 0.0001
322 PRODUCT USE COMPLAINT 1 0.0001
323 PNEUMOTHORAX 1 0.0001
324 HALLUCINATION, AUDITORY 1 0.0001
325 HYPOGLYCAEMIA 3 0.0001
326 MUSCLE TIGHTNESS 1 0.0001
327 INCORRECT DOSE ADMINISTERED 14 0.0001
328 TREATMENT FAILURE 5 0.0001
329 BACK PAIN 14 0.0001
330 BLOOD PRESSURE DECREASED 4 0.0001
331 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
332 TYPE 2 DIABETES MELLITUS 2 0.0001
333 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
334 ASTHENIA 22 0.0001
335 SCAR 1 0.0001
336 DIZZINESS 29 0.0001
337 PARANOIA 1 0.0001
338 ORTHOSTATIC HYPOTENSION 1 0.0001
339 RASH MACULAR 2 0.0001
340 HYPERKALAEMIA 2 0.0001
341 HEAD DISCOMFORT 1 0.0001
342 GALLBLADDER DISORDER 1 0.0001
343 FATIGUE 43 0.0001
344 RESTLESS LEGS SYNDROME 1 0.0001
345 FALL 18 0.0001
346 EYE SWELLING 2 0.0001
347 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
348 HEPATIC CIRRHOSIS 1 0.0001
349 HYPOCALCAEMIA 1 0.0001
350 URINARY TRACT INFECTION 9 0.0001
351 INJECTION SITE SWELLING 4 0.0001
352 PULMONARY FIBROSIS 1 0.0001
353 EAR PAIN 1 0.0001
354 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
355 ORAL HERPES 1 0.0001
356 SURGERY 3 0.0001
357 ARTHRITIS 4 0.0001
358 DISABILITY 1 0.0001
359 SINUS DISORDER 1 0.0001
360 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
361 PRODUCT ADMINISTRATION ERROR 1 0.0000
362 DYSPNOEA 28 0.0000
363 DYSKINESIA 2 0.0000
364 BONE MARROW FAILURE 1 0.0000
365 FLUSHING 5 0.0000
366 PRODUCT PREPARATION ERROR 1 0.0000
367 POLLAKIURIA 2 0.0000
368 INTENTIONAL DRUG MISUSE 1 0.0000
369 ABDOMINAL DISCOMFORT 8 0.0000
370 MOUTH ULCERATION 1 0.0000
371 HALLUCINATION, VISUAL 1 0.0000
372 MYALGIA 8 0.0000
373 EATING DISORDER 1 0.0000
374 RETCHING 1 0.0000
375 JOINT INJURY 1 0.0000
376 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
377 PRODUCT PRESCRIBING ISSUE 1 0.0000
378 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
379 RENAL FAILURE 6 0.0000
380 TRANSAMINASES INCREASED 1 0.0000
381 HEADACHE 28 0.0000
382 SNEEZING 1 0.0000
383 PARAESTHESIA 7 0.0000
384 PANCREATITIS ACUTE 1 0.0000
385 MUSCULAR WEAKNESS 5 0.0000
386 SKIN IRRITATION 2 0.0000
387 MALAISE 19 0.0000
388 PERICARDIAL EFFUSION 1 0.0000
389 ARRHYTHMIA 2 0.0000
390 MIGRAINE 4 0.0000
391 BLOOD GLUCOSE DECREASED 2 0.0000
392 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
393 DIABETIC KETOACIDOSIS 1 0.0000
394 JOINT SWELLING 5 0.0000
395 FIBROMYALGIA 1 0.0000
396 ARTHRALGIA 17 0.0000
397 EXTRAPYRAMIDAL DISORDER 1 0.0000
398 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
399 GASTRIC CANCER 1 0.0000
400 ACUTE KIDNEY INJURY 6 0.0000
401 DRUG RESISTANCE 1 0.0000
402 SKIN ULCER 1 0.0000
403 RESPIRATORY TRACT INFECTION 1 0.0000
404 MUSCULOSKELETAL PAIN 2 0.0000
405 JOINT STIFFNESS 1 0.0000
406 ANHEDONIA 1 0.0000
407 CARDIAC FAILURE 3 0.0000
408 FEAR 1 0.0000
409 DISTURBANCE IN ATTENTION 2 0.0000
410 FREQUENT BOWEL MOVEMENTS 1 0.0000
411 DRY MOUTH 3 0.0000
412 THROAT TIGHTNESS 1 0.0000
413 LIMB INJURY 1 0.0000
414 PALLOR 1 0.0000
415 PNEUMONITIS 1 0.0000
416 TREATMENT NONCOMPLIANCE 2 0.0000
417 SKIN LESION 1 0.0000
418 INFLUENZA LIKE ILLNESS 3 0.0000
419 TARDIVE DYSKINESIA 1 0.0000
420 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
421 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
422 RED BLOOD CELL COUNT DECREASED 1 0.0000
423 SOMNOLENCE 7 0.0000
424 LETHARGY 2 0.0000
425 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
426 NASAL CONGESTION 2 0.0000
427 ACUTE MYOCARDIAL INFARCTION 1 0.0000
428 FEELING ABNORMAL 8 0.0000
429 OFF LABEL USE 29 0.0000
430 VERTIGO 2 0.0000
431 DRUG ADMINISTRATION ERROR 1 0.0000
432 EMOTIONAL DISORDER 1 0.0000
433 HYPERSENSITIVITY 6 0.0000
434 NERVOUS SYSTEM DISORDER 1 0.0000
435 DRUG-INDUCED LIVER INJURY 1 0.0000
436 HEAD INJURY 1 0.0000
437 HYPOTHYROIDISM 1 0.0000
438 METABOLIC ACIDOSIS 1 0.0000
439 DRUG INEFFECTIVE 41 0.0000
440 EXPIRED PRODUCT ADMINISTERED 1 0.0000
441 VIRAL INFECTION 1 0.0000
442 DEHYDRATION 4 0.0000
443 GAIT INABILITY 1 0.0000
444 EYE PRURITUS 1 0.0000
445 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
446 HAEMATURIA 1 0.0000
447 ABDOMINAL PAIN UPPER 6 0.0000
448 DELIRIUM 1 0.0000
449 DEVICE USE ERROR 1 0.0000
450 INJURY 2 0.0000
451 HYPOXIA 1 0.0000
452 SLEEP DISORDER 2 0.0000
453 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
454 CEREBRAL HAEMORRHAGE 1 0.0000
455 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
456 PAIN 17 0.0000
457 INFECTION 4 0.0000
458 DRUG EFFECT INCOMPLETE 1 0.0000
459 RESPIRATORY FAILURE 2 0.0000
460 RESTLESSNESS 1 0.0000
461 BRONCHITIS 2 0.0000
462 INFLUENZA 3 0.0000
463 EPISTAXIS 2 0.0000
464 HYPOAESTHESIA 4 0.0000
465 DYSPNOEA EXERTIONAL 1 0.0000
466 HOT FLUSH 2 0.0000
467 DIARRHOEA 17 0.0000
468 DIABETES MELLITUS 2 0.0000
469 GAIT DISTURBANCE 5 0.0000
470 HYPOTENSION 5 0.0000
471 THROMBOSIS 2 0.0000
472 PNEUMONIA 8 0.0000
473 PSORIATIC ARTHROPATHY 1 0.0000
474 RHABDOMYOLYSIS 1 0.0000
475 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
476 URTICARIA 4 0.0000
477 RENAL IMPAIRMENT 2 0.0000
478 OSTEOARTHRITIS 1 0.0000
479 LOSS OF CONSCIOUSNESS 3 0.0000
480 DEATH 20 0.0000
481 MENTAL DISORDER 1 0.0000
482 INSOMNIA 6 0.0000
483 PULMONARY OEDEMA 1 0.0000
484 WEIGHT INCREASED 5 0.0000
485 MUSCLE SPASMS 4 0.0000
486 SKIN DISCOLOURATION 1 0.0000
487 HYPOKALAEMIA 1 0.0000
488 OROPHARYNGEAL PAIN 2 0.0000
489 CHEST PAIN 4 0.0000
490 DECREASED APPETITE 5 0.0000
491 BLOOD CHOLESTEROL INCREASED 1 0.0000
492 CARDIAC DISORDER 2 0.0000
493 DYSPHAGIA 2 0.0000
494 ANAEMIA 4 0.0000
495 PRODUCTIVE COUGH 1 0.0000
496 RASH 9 0.0000
497 LUNG DISORDER 1 0.0000
498 PRODUCT DOSE OMISSION ISSUE 6 0.0000
499 PYREXIA 7 0.0000
500 SYNCOPE 2 0.0000
501 CHEST DISCOMFORT 2 0.0000
502 HOSPITALISATION 3 0.0000
503 HAEMOGLOBIN DECREASED 2 0.0000
504 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
505 VOMITING 9 0.0000
506 SPEECH DISORDER 1 0.0000
507 NAUSEA 15 0.0000
508 DEPRESSED MOOD 1 0.0000
509 RASH PRURITIC 1 0.0000
510 CONSTIPATION 4 0.0000
511 ARTHROPATHY 1 0.0000
512 SEPSIS 2 0.0000
513 BLISTER 1 0.0000
514 HYPONATRAEMIA 1 0.0000
515 DEPRESSION 4 0.0000
516 HERPES ZOSTER 1 0.0000
517 PRODUCT SUBSTITUTION ISSUE 1 0.0000
518 DYSPHONIA 1 0.0000
519 CATARACT 1 0.0000
520 IRRITABILITY 1 0.0000
521 EMOTIONAL DISTRESS 2 0.0000
522 CONDITION AGGRAVATED 5 0.0000
523 FEELING HOT 1 0.0000
524 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
525 HYPERHIDROSIS 2 0.0000
526 DEEP VEIN THROMBOSIS 1 0.0000
527 BLOOD CREATININE INCREASED 1 0.0000
528 PSORIASIS 2 0.0000
529 ALOPECIA 3 0.0000
530 FEBRILE NEUTROPENIA 1 0.0000
531 HEPATIC ENZYME INCREASED 1 0.0000
532 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
533 BURNING SENSATION 1 0.0000
534 HYPERTENSION 3 0.0000
535 THERAPY INTERRUPTED 1 0.0000
536 SKIN BURNING SENSATION 1 0.0000
537 UNDERDOSE 1 0.0000
538 HALLUCINATION 1 0.0000
539 UNEVALUABLE EVENT 1 0.0000
540 PERIPHERAL SWELLING 2 0.0000
541 ABDOMINAL PAIN 3 0.0000
542 DRUG INTERACTION 2 0.0000
543 INJECTION SITE HAEMORRHAGE 1 0.0000
544 TOXICITY TO VARIOUS AGENTS 2 0.0000
545 SKIN EXFOLIATION 1 0.0000
546 PRODUCT STORAGE ERROR 1 0.0000
547 MUSCULOSKELETAL STIFFNESS 1 0.0000
548 TACHYCARDIA 1 0.0000
549 NO ADVERSE EVENT 2 0.0000
550 WEIGHT DECREASED 3 0.0000
551 BREAST CANCER 1 0.0000
552 BLOOD GLUCOSE INCREASED 2 0.0000
553 PULMONARY EMBOLISM 1 0.0000
554 NEUROPATHY PERIPHERAL 1 0.0000
555 PRURITUS 4 0.0000
556 ATRIAL FIBRILLATION 1 0.0000
557 DYSPEPSIA 1 0.0000
558 ILLNESS 1 0.0000
559 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
560 HAEMORRHAGE 1 0.0000
561 OVERDOSE 2 0.0000
562 RHEUMATOID ARTHRITIS 1 0.0000
563 SEIZURE 1 0.0000
564 DISEASE PROGRESSION 1 0.0000
565 PRODUCT QUALITY ISSUE 1 0.0000
566 NEUTROPENIA 1 0.0000
567 INJECTION SITE PAIN 2 0.0000
568 DRUG DOSE OMISSION 1 0.0000
569 COVID-19 1 0.0000
570 PRODUCT USE ISSUE 1 0.0000
571 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
572 ERYTHEMA 1 0.0000
573 COUGH 1 0.0000